Mildronat caps 250mg #40

International name: Mildronate 250 mg #40 capsules

Indications for use:

Meldonium is used as part of complex therapy in the following cases:

• Reduced work capacity, physical and psycho-emotional overload;

• Recovery period after cerebrovascular disorders, head injuries, and encephalitis.

Composition:

Capsules:

1 capsule contains 250 mg of meldonium dihydrate.

Excipients:

Dried potato starch, silicon dioxide, calcium stearate.
Capsule (body and cap): titanium dioxide (E 171), gelatin.

Dosage, course duration, and administration:

For oral use. Considering the possible development of a stimulating effect, it is recommended to take it in the first half of the day.

Adults:

The daily dose is 500 mg (2 capsules). The daily dose can be taken as a single dose or divided into 2 parts. The maximum daily dose is 500 mg.
The duration of the treatment course is 4–6 weeks. The treatment course can be repeated 2–3 times a year.

Elderly:

In elderly patients with impaired liver and/or kidney function, a dose reduction of meldonium may be required.

Patients with impaired kidney function:

Since the drug is excreted through the kidneys, patients with mild to moderate renal impairment should be prescribed meldonium at a reduced dose.

Patients with impaired liver function:

Patients with mild to moderate liver impairment should be prescribed meldonium at a reduced dose.

Pediatric population:

There is no data on the safety and efficacy of meldonium use in children and adolescents (under 18 years), therefore this drug is contraindicated in children and adolescents.

Contraindications:

Hypersensitivity to meldonium or any other ingredient of the preparation;
Severe liver and/or kidney failure (insufficient data on safety of use);
Pregnancy and lactation;
Children and adolescents under 18 years of age (safety of use has not been established).

Storage conditions:

Store at a temperature up to 25°C.
Keep in the original packaging to protect from moisture.
Keep out of reach of children.